# Charles J. Ryan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-j-ryan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,197 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 71 |
| i10-index | 236 |
| Last Known Institution | University of Minnesota |
| OpenAlex ID | https://openalex.org/A5012804612 |
| ORCID iD | https://orcid.org/0000-0002-2081-3557 |
| Works | 794 |

## Researcher papers

- [Abiraterone and Increased Survival in Metastatic Prostate Cancer](https://scholariq.org/papers/abiraterone-and-increased-survival-in-metastatic-prostate-cancer/)
- [Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy](https://scholariq.org/papers/abiraterone-in-metastatic-prostate-cancer-without-previous-chemotherapy/)
- [Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3](https://scholariq.org/papers/trial-design-and-objectives-for-castration-resistant-prostate-cancer-updated/)
- [Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer](https://scholariq.org/papers/genomic-hallmarks-and-structural-variation-in-metastatic-prostate-cancer/)
- [Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-the-report-of-the-advanced/)
- [Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer](https://scholariq.org/papers/platinum-based-chemotherapy-for-variant-castrate-resistant-prostate-cancer/)
- [Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-report-of-the-advanced/)
- [Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy](https://scholariq.org/papers/associations-of-luminal-and-basal-subtyping-of-prostate-cancer-with-prognosis/)
- [Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP Inhibitors](https://scholariq.org/papers/analysis-of-circulating-cell-free-dna-identifies-multiclonal-heterogeneity-of-i/)
- [Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data](https://scholariq.org/papers/prediction-of-overall-survival-for-patients-with-metastatic-castration-resistant/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

## Researcher university

- [University of Minnesota](https://scholariq.org/institutions/university-of-minnesota/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.